Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis (Q31057145)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis
scientific article

    Statements

    Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis (English)
    Steven D Nathan
    Carlo Albera
    Williamson Z Bradford
    Roland M du Bois
    Elizabeth A Fagan
    Robert S Fishman
    Ian Glaspole
    Marilyn K Glassberg
    Talmadge E King
    Lisa Lancaster
    Zhengning Lin
    Carlos A Pereira
    Jeffrey J Swigris
    Dominique Valeyre
    Paul W Noble
    Athol U Wells
    11 March 2016
    429-435

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit